Skip to main content

Table 3 Comparison of the drug resistance of major gram-negative bacteria to commonly used antibacterial agents between nosocomial and community-acquired SBP

From: Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: community-acquired versus nosocomial infections

Antibiotics

Escherichia coli (n = 81)

Klebsiella pneumoniae (n = 40)

Nosocomial

(n = 32)

Community-acquired (n = 49)

p value

Nosocomial

(n = 14)

Community-acquired (n = 26)

p value

ESBL

25 (78.1)

15 (30.6)

0.000

4 (28.6)

2 (7.7)

0.194

Ampicillin

29 (90.6)

43 (87.8)

0.968

14 (100)

24 (92.3)

0.533

Piperacillin

28 (87.5)

37 (75.5)

0.299

6 (42.9)

3 (11.5)

0.062

Amoxicillin-clavulanic acid

12 (37.5)

10 (20.4)

0.091

3 (21.4)

1 (3.8)

0.224

Piperacillin/tazobactam

4 (12.5)

0

0.022

2 (14.3)

0

0.117

Cefazolin

26 (81.2)

13 (26.5)

0.000

4 (28.6)

4 (15.4)

0.562

Ceftazidime

25 (78.1)

13 (26.5)

0.000

4 (28.6)

2 (7.7)

0.194

Cefotaxime

27 (84.3)

15 (30.6)

0.000

4 (28.6)

2 (7.7)

0.194

Cefepime

23 (71.9)

11 (22.4)

0.000

4 (28.6)

0

0.011

Aztreonam

18 (56.3)

10 (20.4)

0.001

2 (14.3)

1 (3.8)

0.571

Imipenem

2 (6.3)

0

0.153

2 (14.3)

0

0.117

Meropenem

1 (3.1)

0

0.395

1 (7.1)

0

0.350

Amikacin

2 (6.3)

0

0.153

1 (7.1)

0

0.350

Levofloxacin

23 (71.9)

21 (42.9)

0.01

3 (21.4)

1 (3.8)

0.224

SMZ

21 (65.6)

30 (61.2)

0.688

3 (21.4)

4 (15.4)

0.965

Gentamicin

17 (53.1)

25 (51.0)

0.853

2 (14.3)

2 (7.7)

0.912

Tetracycline

25 (78.1)

39 (79.6)

0.874

4 (28.6)

4 (15.4)

0.562